Population
Patients with pulmonary arterial hypertension occurring after surgical treatment of tetralogy of Fallot…
Design
Review
Authors
Loading...
Proposed subclassifications for PAH in TOF/MAPCAs may refine vasodilator candidacy; leaves open validation and practice change pending multicenter registry data.
New subclassifications for PAH associated with Tetralogy of Fallot and MAPCAs are proposed to better categorize patients and guide the use of pulmonary vasodilators.
Yasuhara et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: